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11 ABSTRACT: This review analyzes the outcomes and
12 technical aspects of in vivo studies published in the past
13 decade using gels and hydrogels for cartilage repair. Using
14 PubMed search engine, original research publications during
15 the period of 2002/01/01 to 2015/04/30 identiﬁed 115
16 published papers. Of these, 3 studies failed to ﬁnd a statistically
17 signiﬁcant improvement of treatment group as compared to
18 control and 18 studies did not clearly identify hyaline-like
19 cartilage formation in the treated groups. The most frequent
20 repaired lesion was the rabbit acute full thickness trochlear
21 defect, using a scaﬀold combining a gel or hydrogel and other
22 material. One third of the scaﬀolds were cell-free (35%) and
23 the majority of the studies did not use growth factors (71%).
24 The present review may constitute a useful tool in design of future studies, as limitations of study designs are pointed and results
25 in terms of translation to human application is discussed.
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1. INTRODUCTION
27 Articular cartilage has limited intrinsic capacity for self-repair,
28 because of the lack of vascular, neural, and lymphatic networks,
29 as well as absence of progenitor cells.1,2 According to Hjelle et
30 al, cartilage lesions were found in 60% of patients submitted to
31 knee arthroscopy.3 Cartilage lesions commonly progress to
32 osteoarthritis (OA), as a ﬁnal state of disease evolution.2,4
33 Presently, it is estimated that 10−15% of adults over 60 years
34 old show some symptoms of disease and by 2050, 130 million
35 people will suﬀer from osteoarthritis worldwide.5 The clinical
36 and economic impact is impressive, as the estimated direct and
37 indirect costs related to OA has surpassed $65 billion annually.6
38 At earlier stages of cartilage damage, current therapies for
39 cartilage repair of lesions are not satisfactory as they fail to
40 restore a normal hyaline cartilage.7−9 Surgical approaches can
41 include microfracture, resurfacing techniques, and osteochon-
42 dral grafting.8−10 Autologous chondrocyte implantation (ACI)
43 and matrix-assisted autologous chondrocyte implantation
44 (MACI) are advanced approaches for regeneration of cartilage
45 lesions.9,10
46 Microfracture and resurfacing techniques are easy to perform,
47 cost competitive, widely adopted, and well-documented
48 techniques that relieve symptomatic patients. However,
49regenerated tissue is composed mostly by ﬁbrocartilage, thus
50providing short-term positive results in small cartilage
51lesions.8,10
52Osteochondral grafting, the direct transplantation of an
53osteochondral autograft (mosaicplasty) or allograft, is the only
54technique available that satisfactorily restores hyaline cartilage.4
55However, donor site morbidity, risk of disease transmission,
56possible graft-versus-host immune response (in the case of
57allografts) and osteoarthritic exacerbation can occur due to lack
58of congruency between treated and untreated surfaces, thus
59limiting the use of those techniques.4
60On the other hand, ACI and MACI are expensive techniques,
61which demand complex protocols and two diﬀerent surgeries.
62Promising results have been reported,4 but poor consistence of
63clinical outcomes with time, cells and/or cartilage fragment
64loosening, arthroﬁbrosis, osteophytes development, synovitis,
65infection and chondromalacea have been described.4,10
66Many of the limitations of current available treatments justify
67the quest for more eﬀective approaches and development of
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68 new biomaterials for cartilage repair. Interestingly, hydrogels
69 have attracted great deal of attention because of its performance
70 characteristics, i.e., are soft, of synthetic or natural origin, and
71 can form three-dimensional networks that can be tuned for its
72 biocompatibility, bioadhesiveness, and biodegradability.11,12
73 Hydrogels present other advantageous features for tissue
74 engineering applications,11−14 such as extracellular matrix
75 mimetic; swelling ability while maintaining shape; capability
76 to undergo volume phase or sol−gel phase transitions in
77 response to physical and/or chemical stimuli; tunable surface
78 and bulk properties to modulate cells adhesion and
79 thrombogenicity; support to high diﬀusion kinetics of nutrients
80 and metabolic products within the construct.
81 There are several chemical or physical cross-linking
82 techniques, photopolymerization, or even microfabrication
83 technologies,13,15,16 which can optimize hydrogel physicochem-
84 ical characteristics and biological behavior,13 and improve
85 performance of hydrogels in cartilage tissue engineering
86 strategies. Furthermore, hydrogels can be combined with
87 other materials improving its properties.17−19
88 The application of hydrogels as volume ﬁllers and cell
89 carriers can contribute signiﬁcantly to the development of more
90 eﬀective regeneration strategies20 in irregular shape cartilage
91 defects. Additionally, the opportunity to treat such lesions by a
92 single step procedure using simpler surgical protocols, in which
93 an injectable solution is delivered by a minimally invasive
94 procedure, can minimize signiﬁcantly treatment cost, improve
95 patient safety and comfort, and support treatment in an
96 outpatient setting.
97 This review compiles in vivo studies reporting the use of
98 hydrogels for repairing cartilage lesions and analyzes its
99 performance in diﬀerent animal models. A thorough analysis
100 of experimental variables was further performed, constituting a
101 useful tool for researchers when designing future in vivo studies
102 for cartilage repair.
2. METHODS
103 2.1. Keyword-Based Search. Original research publications were
104 identiﬁed by the use of PubMed search engine, during the period
105 comprised between 2002/01/01 and 2015/04/30, and using the
106 following keywords: “cartilage”, “osteochondral”, “cartilage repair”,
107 “tissue engineering”, “scaﬀold”, “cells”, “gel”, “gels”, “hydrogel”, and
108 “hydrogels”, using AND/OR Boolean operators. The terms such as
109“eye”, “heart”, “tooth”, “skin”, “root”, “dermal”, “dentin”, “cardiovas-
110cular”, “hepatic”, “gastric”, “gastrointestinal”, and “biochemistry” were
111excluded.
1122.2. Inclusion/Exclusion Selection. All abstracts were evaluated
113by four independent reviewers based on the following inclusion
114criteria: English language, and experimental protocol reporting in vivo
115use of hydrogels in repair of cartilage defects. The following exclusion
116were applied: Other language rather than English; in vitro studies;
117studies not involving use of hydrogels; studies reporting use of
118hydrogels in other application contexts or studies in which the
119hydrogel could not be considered as a scaﬀold. Whenever the abstract
120was unclear or insuﬃcient for determination of its inclusion/exclusion,
121the Materials and Methods section and/or the complete publication
122were analyzed before a decision was made.
1232.3. Evaluation and Final Selection. After selection of abstracts,
124a second evaluation was carried out, during which all publications were
125analyzed and discussed among the four reviewers in order to produce
126the ﬁnal list of publications to be overviewed.
1272.4. Full Text Review. All included articles were submitted to a
128full-text review. For each paper, the respective list of references was
129veriﬁed to identify possible relevant studies that might have been
130undetected through PubMed-based search.
3. RESULTS
1313.1. Publication Selection and Review. Keyword based
132search identiﬁed a total of 14295 publications. After inclusion/
133exclusion selection, 902 papers related to study of articular
134cartilage repair have been identiﬁed. Then, evaluation and ﬁnal
135selection of those papers, according to deﬁned inclusion and
136exclusion criteria, identiﬁed a total of 93 papers. During the
137selection process, 809 studies have been excluded due to several
138reasons, such as in vitro experimental protocol, experiments not
139aimed at repairing cartilage defects, or papers reporting clinical
140investigations. For each paper, the list of references was veriﬁed,
141which allowed identiﬁcation of 22 additional publications.
142Herein, the total number of published original articles
143identiﬁed, reviewed and included was 115.
1443.2. Distribution of Publications Per Year. The
145 f1distribution of publications per year is shown in Figure 1.
146Between 2002 and 2010, the number of publications reporting
147in vivo experiments concerning cartilage repair have increased
148every year. After 2010, the number of publications per year
149appears to have stabilized between 10 and 13 papers per year.
1503.3. Animal Models. Upon analysis of the publications,
151 f2several outcomes were obtained regarding animal models and
Figure 1. Number of original scientiﬁc publications per year published between 2002 and 2014 reporting in vivo experiments on cartilage repair
according to animal model.
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f2 152 respective experimental protocol (Figure 2). According to
153 Figure 2A, the rabbit model was the most common for studying
154 cartilage repair by means of using hydrogels, comprising 73.3%
155 of all studies. Noticeably, other animal models selected for
156 evaluation of hydrogel performance included large animals,
157 such as goat and sheep models, representing 3.1 and 5.3% of all
158 studies, respectively (Figure 2A). Minipigs were the second
159 animal more frequently used comprising 9.9% of all studies
160 (Figure 2A).
t1 161 3.3.1. Age and Weight of Animals. Table 1 summarizes the
162 data regarding age and weight of animals for all the studies
163 analyzed. The absolute ranges depend very much on the animal
164 model. The animal model with the wider age interval was the
165sheep, with a relative interval of 40−260 weeks. As concerns
166weight, the animal models with wider weight intervals were
167sheep and horse, with a relative interval of 22.5 to 80 kg and
168307 to 439 kg, respectively.
169 t23.3.2. Number of Animals Per Study. Table 2 presents the
170number of animals used for each study and the time interval for
171the time points according to each animal model. The most
172common number of animals used per study was 12, as this was
173the mode obtained for mini-pig, rabbit, and sheep models. As
174for the duration of the studies, 12 weeks was the mode obtained
175for the most used animal models, rabbit and mini-pig, yet
176ranging from 4 and 8 to 52 weeks, respectively.
1773.4. Experimental Protocol. 3.4.1. Type and Geometry of
178Defects. From Figure 2, it is possible to state that the most
179frequently induced cartilage defect was a full thickness lesion
180(80%, Figure 2B), done in the trochlea (63%, Figure 2C) by
181drilling (67%, Figure 2D) and treated at an acute stage (95%,
182Figure 2E).
183Cartilage defect dimensions were also thoroughly analyzed,
184 t3including area, depth, and volume (Table 3). Most defects had
185a circular shape, yet 8 articles reported a rectangular or square
186shape.21−28 Therefore, for comparison purposes, it was adopted
187the defect area to characterize surface dimension. Dimensions
188varied according to the animal model employed. In general,
189dimensions of induced cartilage defect were proportional to the
190size of the animal. For rat, the minimum area of the lesion was
1910.6 mm2 and for horse the maximum area was 176.7 mm2. For
192rabbit, the most frequently adopted animal model, the mode of
193the lesion area was 7.1 mm2, whereas the lesion area varied
194between 1.8 and 200 mm2. The very large variation in defect
195area results from one study where the defect included the
196complete excision of tibial plateau.29
1973.4.2. Type of Scaﬀold. From Figure 2F, it is evident that
198“combined materials” prevail as the most frequent type of
199scaﬀold (51%). These are composed by two or more materials
200of either of natural or of synthetic origin. The other types of
201scaﬀold that has been mostly investigated were natural derived
202scaﬀolds (39%) and synthetic scaﬀolds (10%).
203When analyzing use of scaﬀolds with cells, about 65% of all
204studies analyzed involved the use of cells, in a so-called
205combination repair strategy. Nevertheless, about 35% of
206 f3cartilage lesions where treated with hydrogels alone (Figure
207 f33A).
2083.4.3. Type of Cells. For combination approaches where
209scaﬀolds are combined with cells, 27% of studies used
210chondrocytes, whereas 38% used mesenchymal stem cells
211(Figure 2G). A thorough description of cell types and
212concentrations used in the analyzed studies are displayed in
213 t4Table 4. Chondrocytes were the most widely used cell type in a
214concentration range between 5.00 × 104 and 5.00 × 107 cells/
215mL, followed by mesenchymal stem cells (MSC) that have
216been used in a range between 1.50 × 105 and 7.20 × 105 cells/
217mL. We noticed that 35% of the scaﬀolds were cell-free.
2183.4.4. Bioactive Agents. Besides the use of cells with the
219hydrogels in combination strategies to repair cartilage lesions,
220growth factors have been also explored to improve quality of
221regenerated tissue. According to Figure 2H, published papers
222used at least one growth factor (29%) for repair of cartilage
223lesions. Transforming growth factor (TGF) was the most
224frequent choice, accounting for 11% of studies, whereas bone
225morphogenetic protein (BMP) and ﬁbroblast growth factor
226(FGF) were each used in 3 and 2% of all studies, respectively.
227Insulin growth factor (IGF), growth diﬀerentiation factor
Figure 2. Distribution of animal models, characterization of the
induced defect and lesion treatment and bioactive agents used: (A)
animal model; (B) lesion type; (C) location of the lesion; (D)
techniques for defect induction; (E) disease stage; (F) type of scaﬀold;
(G) type of cells: adipose mesenchymal stem cells (aMSC), muscle
mesenchymal stem cells (mMSC), synovium mesenchymal stem cells
(sMSC), bone-marrow mesenchymal stem cells (bmMSC) and human
mesenchymal stem cells (HMSC); (H) growth factors: transforming
growth factor (TGF), bone morphogenetic protein (BMP), ﬁbroblast
growth factor (FGF), platelet-rich plasma (PRP).
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228 (GDF), connective tissue growth factor (CTGF), and Nel-like
229 molecule-1 (NELL-1) account for a total of 3% of studies
230 (Figure 2H). Noticeably, platelet-rich plasma (PRP) has also
231 considerable expression in this context, accounting for 2% of all
232 studies (Figure 2H).
t5 233 3.4.5. Time Points and Study Groups. Table 5 presents
234 number of time points, number of study groups, and number of
235 lesions per study group for the analyzed publications.
236 Concerning the number of time points, the majority of studies
237 included at least 2 time points, yet the number ranged from 1
238 time point up to 7 time points. Three study groups was the
239 most common among all animal models, yet the number of
240 lesions per study group averaged 12−15.4, for the mini-pig and
241 rabbit models, respectively.
242 For all animal models, the number of study groups was
243 between 2 and 9. Concerning the number of lesions by study
244 group (N), this index was calculated according the equation:
= ×N no. of animals no. of lesions by animal
no. of study groups
245According to Table 5, the number of lesions per study groups
246was between 3 and 74.0.
2473.4.6. Characterization of Cartilage Repair. Several
248techniques have been used to evaluate regeneration of cartilage
249tissue within the induced lesions. Histological staining of
250cartilage explants were done in all studies, including
251hematoxylin and eosin staining in most of the studies,
252complemented with at least one of the following: alcian blue,
253toluidine blue, safranin O, and/or Masson’s trichrome staining.
254Immunohistochemistry staining, commonly used for identi-
255ﬁcation of collagen type II and/or collagen type I, were done in
25671 reports. For histological evaluation several histological scores
257were chosen: O’Driscoll, Pineda, ICRS, Mankin, Moran,
258Wakitani, Wayne, Sellerś, Caplan, and Susante. In 15 papers,
259two of the previous scores were used simultaneously. O’Driscoll
Table 1. Maximum, Minimum, Average, and Mode of Age and Weight of Animals Used for in Vivo Experiments on Cartilage
Repair According to Animal Model As Reported in Analyzed Publicationsa
Age (Weeks) Weight (Kg)
Animal Max Min Avg Mode Max Min Avg Mode
dogb 104.0 9.4
goat 47.6 23.9 33.8
horse 182 156 169.0 439.0 307.0 373.0
mini pig 156 16 43.2 24/32/44 42.0 11.0 26.2 36.5
monkeyb 312.0 8.0
rabbit 96 8 20.8 24 4.7 1.8 3.1 2.3/3.3
rat 12 5 10.7 12 0.4 0.3 0.3
sheep 260 40 152.4 117 80.0 22.5 64.9 68.0/80.0
aAbbreviations: max, maximum; min, minimum; avg, average. bOnly 1 study with this animal model.
Table 2. − Maximum, Minimum, Average, and Mode of the Number of Animals and Duration of Study Adopted for in Vivo
Experiments on Cartilage Repair According to Animal Model As Reported in Analyzed Publicationsa
no. of animals/paper duration (weeks)
animal max min avg mode max min avg mode
dogb 9.0 10.0
goat 20 4 12.5 24 12 19.0 24
horse 6 6 6.0 32 24 28.0
mini pig 27 6 14.8 12/16/18/20 52 8 20.0 1
monkeyb 16.0 24.0
rabbit 81 3 27.3 12 52 4 13.9 12
rat 121 9 40.2 12 4 7.0
sheep 24 3 11.4 10/12 52 3 27.0 16/52
aAbbreviations: max, maximum; min, minimum; avg, average. bOnly 1 study with this animal model.
Table 3. Maximum, Minimum, Average, and Mode of the Number of Lesions, Lesion Area, Lesion Depth, and Lesion Volume
Adopted for in Vivo Experiments on Cartilage Repair According to Animal Model As Reported in Analyzed Publicationsa
no. of lesions lesion area (mm2) lesion depth (mm) lesion volume (mm3)
animal max min avg mode max min avg mode max min avg mode max min avg mode
dogb 2.0 19.6 4.5 88.4
goat 2 2 2.0 2 28.3 19.6 24.0 4.0 3.0 3.3 3.0 113.1 58.9 78.9 58.9
horse 2 2 2.0 176.7 176.7 176.7 2.8 2.8 2.8 486.0 486.0 486.0
mini pig 8 1 2.8 2 56.7 12.6 32.3 28.3 6.0 1.0 2.6 1.0/3.0 169.6 28.3 87.1 28.3
monkeyb 2.0 7.1 5.0 35.3
rabbit 6 1 2.1 2 200.0 1.8 15.4 7.1 15.0 0.5 3.7 3.0 217.8 3.5 51.0 21.2
rat 2 1 1.5 1 3.1 0.6 1.9 1.8 2.0 1.0 1.5 6.3 1.8 3.3
sheep 12 1 5.0 4 50.3 8.0 32.4 28.3/38.5 12.0 2.0 6.7 12.0 423.1 32.2 205.5 77.0/339.3
aAbbreviations: max, maximum; min, minimum; avg, average. bOnly 1 study with this animal model.
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Figure 3. Correlation of data variables. (A) Inner circle: distribution of scaﬀold type used in each animal model; outer circle: eﬃcacy of each scaﬀold
type in forming hyaline cartilage. Lateral column displays overall eﬃcacy of the animal model in yielding hyaline cartilage outcomes, further
discriminated by scaﬀold type. (B1) Inner circle: distribution of cell ± growth factors used in each scaﬀold type; outer circle: eﬃcacy of each cell ±
growth factor combination in forming hyaline cartilage. Lateral column displays overall eﬃcacy of scaﬀold type in yielding hyaline cartilage outcomes,
further discriminated by cell ± growth factor combination. (B2) Inner circle: distribution of lesion area used in each scaﬀold type; outer circle:
eﬃcacy of lesion area in yielding hyaline cartilage outcomes. (B3) Inner circle: distribution of lesion type used in each scaﬀold type; outer circle:
eﬃcacy of lesion type in yielding hyaline cartilage outcomes.
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260 scoring was used, alone or combined with another score, in 29
261 publications, followed by Wakitani scoring in 20 studies and by
262 the ICRS scoring in 19 papers. In 32 studies, no histological
263 score was used to evaluate the quality of cartilage regeneration.
264 As outcome of histological evaluation, most studies have
265 obtained statistically signiﬁcant improvement in cartilage
266 regeneration for treated groups as compared to control groups.
267 In 3 papers,
30−32 no signiﬁcant histological improvement was
268 observed between treated and untreated groups, and in 4
269papers,
33−36 no histological diﬀerences were found between
270study groups. Most studies reported on the development of
271hyaline-like cartilage, while 8 studies
37−44 reported no cartilage
272like tissue or a mixture of ﬁbrous cartilage and hyaline-like
273cartilage in the repaired tissue. In 14 studies,
23,30−32,45−51 the
274repair tissue was not classiﬁed as hyaline-like cartilage. In 5
275papers,
21,52−54 a tendency for deterioration of cartilage tissue
276along time was reported.
Table 4. Maximum, Minimum, and Average Number of Cells Used for in Vivo Experiments on Cartilage Repair According to
Cell Type and Animal Model As Reported in Analyzed Publicationsa
animal
cell type
cell
concentration
(cells/mL) dogb goat horse mini pig monkeyb rabbit rat sheep
aMsc max 1.50 × 1007 1.00 × 1006
min 1.00 × 1006 1.00 × 1006
avg 9.00 × 1006 1.00 × 1006
bMsc max 5.00 × 1007 7.00 × 1006 1.00 × 1006 5.00 × 1007 7.20 × 1005
min 5.00 × 1007 1.00 × 1005 1.00 × 1006 1.50 × 1005 4.00 × 1005
avg 1.00 × 1007 5.00 × 1007 2.28 × 1006 1.00 × 1006 1.28 × 1007 5.07 × 1005
BNC max 1.00 × 1005
min 1.00 × 1005
avg 1.00 × 1005
chondrocytes max 5.00 × 1006 5.00 × 1007 5.00 × 1007 5.00 × 1004 4.00 × 1007
min 1.00 × 1006 2.00 × 1005 7.50 × 1004 5.00 × 1004 1.00 × 1006
avg - 3.00 × 1006 1.20 × 1007 1.59 × 1007 5.76 × 1006 5.00 × 1004 1.63 × 1007
HMsc max 1.00 × 1006 2.00 × 1007
min 1.00 × 1006 2.00 × 1007
avg 1.00 × 1006 2.00 × 1007
mMsc max 2.00 × 1006
min 1.00 × 1006
avg 1.50 × 1006
PBC max 2.36 × 1007
min 2.36 × 1007
avg 2.36 × 1007
periostal cells max 8.00 × 1006
min 8.00 × 1006
avg 8.00 × 1006
sMsc max 1.00 × 1008
min 1.00 × 1006
avg 3.82 × 1007
aaMSC: adipose mesenchymal stem cells; bmMSC: bone-marrow mesenchymal stem cells; bmNC: bone-marrow nucleated cells; HMSC: human
mesenchymal stem cells; mMSC: muscle mesenchymal stem cells; PBC: peripheral blood mononuclear cells; sMSC: synovium mesenchymal stem
cells; max, maximum; min, minimum; avg, average. bOnly 1 study with this animal model.
Table 5. Maximum, Minimum, Average, and Mode of the Number of Time Points, Number of Study Groups, and Number of
Lesions Per Study Group Adopted for in Vivo Experiments on Cartilage Repair According to Animal Model As Reported in
Analyzed Publications
no. of time points no. of study groups no. of lesions/study group
animal max min avg mode max min avg mode max min avg
doga 2.0 2.0 9 9 9.0
goat 3 1 2.0 2 4 2 3.0 3 12 3 8.3
horse 2 1 1.5 2 2 2.0 6 6 6.0
mini pig 3 1 1.5 1 5 2 3.1 3 24 5 12.0
monkeya 3.0 2.0 16.0
rabbit 7 1 2.3 2 9 2 3.3 3 74 3 15.4
rat 3 1 1.8 1 7 3 3.9 3 20 13 16.8
sheep 3 1 1.7 1/2 6 2 3.9 4 20 6 10.8
aOnly 1 study with this animal model.
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277 Quantitatively, gene expression was evaluated in 25 studies
278 (21,7%). Characterization of mechanical performance of
279 regenerated tissue was highly uncommon, as it was performed
280 in 8 studies. Imaging evaluation including magnetic resonance
281 imaging (MRI), microcomputed tomography (μ-CT), laser
282 scanning arthroscopy, and optical coherence tomography
283 (OCT) was performed in 19 studies.
284 3.4.7. Side Eﬀects. Several side eﬀects have been reported in
285 the studies analyzed such as inﬂammation, degeneration, tissue
286 hypertrophy, among others. No information was given related
287 to this issue in 26 studies. Inﬂammatory response was reported
288 in 9 studies,24,31,52,55−60 including, synovitis, ﬁbrosis, and
289 ﬁssures. By its turn, 13 papers reported degenerative or
290 pathological changes like osteophytes, cyst formation, or bone
291 hypertrophy. In these studies, one of the following were used: a
292 periostal ﬂap in a chondrocyte cell-laden scaﬀold,21 PRPs,61 a
293 growth factor (TGFβ,62,63 BMP-2,31 FGF52), or cells (ASC,64
294 BMSC,65 MSC,25,54 chondrocytes66 chondrocytes/periostal
295 cells67). In another study,68 the control group developed a
296 degenerative change.
4. DISCUSSION
297 The present systematic review revealed that hydrogels used for
298 cartilage repair include those composed by single natural or
299 synthetic biomaterials, or by combination of these, designated
300 as “combined materials” (Figure 2F). Advantages/disadvan-
301 tages of natural and synthetic biomaterials for cartilage repair
302 are detailed elsewhere.69,70 Among the literature revised, 39% of
303 studies proposed natural materials including colla-
304 g e n , 2 1 , 2 2 , 2 5 , 2 6 , 2 8 , 3 2 , 3 9 , 4 7 , 5 0 , 5 2 , 5 8 , 6 3 , 6 4 , 7 1− 7 6 a l g i -
305 nate,37,38,40,48,62,77−80 ﬁbrin,29,33,81,82 platelet-rich plasma,61,83
306 hyaluronic acid,27,31,57,84,85 gellan gum,86 chitosan,42,87 and
307 sugar cane biopolymer.88 For 10% of studies, synthetic
308 materials included oligo(poly(ethylene glycol) fumarate)
309 (OPF),43,46,89 poly(N-isopropylacrylamide-co-acrylic acid)
310 (poly(NiPAAm-co-AAc)),90 poly(L-lactide-co-3-caprolactone)
311 (PLCL),91,92 Si-HPMC,36 polypeptides,35,65,93 and α-CD-EG
312 4400.94 The scaﬀolds using combined materials were composed
313 by two or more natural materials, representing 51% of the
314 studies,17−19,49,60,66−68,95−100 by association of two or more
315 synthetic polymers,101−109 by the association of natural
316 materials with a synthetic polymer,20,23,44,45,51,54−56,59,76,110−128
317 128 by association of others materials.24,30,34,41,53,129−132 When
t6 318 analyzing Table 6, it is clear that most biomaterials succeed (to
319 a higher or less extent) on regenerating hyaline matrix, while
320 delivering bioactive agents such as cells and/or growth factors,
321 as well as fulﬁlling fundamental requirements for translation
322 into human scenario. Major limitations of these gels/hydrogels
323 relate to unsatisfactory mechanical properties, capable to
324 immediately withstand load after treatment, as well as a
325 mismatch of biomaterial degradation rate as compared to tissue
326 regeneration (either too fast or to slow). The combination of
327 the hydrogel with a rigid scaﬀold has been tested (for example
328 PLCL,23 PLA/PLGA,92 aiming to improve mechanical proper-
329 ties, whereas the downside relates to loss of injectability, and
330 consequently, adequacy of the system to be delivered by a
331 minimally invasive approach. Cross-linking mechanisms diﬀer
332 among the biomaterial types, yet can be used, to a certain
333 extent, to ﬁne-tune mechanical properties as well as degradation
334 rate of the hydrogels. Not less important in the cartilage repair
335 equation, is the capacity to mimic the complex layered structure
336 of articular cartilage tissue. Although current gels and hydrogels
337 are still limited in this regard, future developments in the T
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338 biomaterials ﬁeld might pursue this target, by providing more
339 sophisticated, smart, and multifunctional materials for improved
340 cartilage regeneration.133,134
341 Regarding the animal model used, the rabbit was the
342 preferred, comprising 73.3% of all studies. Rabbits gather
343 several features that make it an attractive model for cartilage
344 regeneration research. It is of easy handling, caging. and care,
345 has a good cost eﬀectiveness and enough dimensions of the
346 trochlear groove and condyles for the induction of a 3−4 mm
347 diameter cartilage defects.135 However, the relatively thin
348 cartilage thickness (approximately 0.4 ± 0.1 mm in the
349 trochlear groove),136 has limited the volume size of the
350 cartilage defect.135 Another limitation of this animal model is
351 the high degree of the rabbit knee ﬂexion, creating a partial
352 weight-bearing condition when the trochlear groove is chosen
353 as location for cartilage defect induction/repair.137 The present
354 review revealed that the majority of studies used were immature
355 rabbits younger than 8 months, the minimum age considered
356 for maturity of rabbits.138 The above-mentioned disadvantages
357 and the high potential of the rabbit model for spontaneous
358 healing,84,139 especially in immature animals, are important
359 limitations to address when the rabbit is used as a translational
360 model to human knee cartilage. Herein, it was noticed a
361 progressive use of larger and more weighted animal models,
362 allowing bigger cartilage defects that reproduce better the size,
363 depth, and conditions of human cartilage lesions.135 Fur-
364 thermore, some of these models, as opposed to rabbit, have a
365 low spontaneous cartilage repair ability,140−142 and similr to
366 humans, suﬀer from osteochondritis dissecans and osteo-
367 arthritis pathologies.135
368 An articular cartilage defect is classiﬁed as full or partial-
369 thickness defect according to the penetration into the
370 subchondral bone.116,143 Considering the known cartilage
371 thickness of the diﬀerent animal models,135,144 the majority of
372 the defects overviewed in this review are deeper than the
373 expected cartilage thickness for those models, therefore, these
374 were classiﬁed as full-thickness defects or as osteochondral
375 defect. This is a very important drawback regarding the
376 relevance of the models used for evaluation of cartilage repair
377 performance, given that in humans superﬁcial cartilage lesions
378 are the most common, and only 5% are osteochondral defects.3
379 Most of the studies have reported the treatment of cartilage
380 defects at an acute stage. From the total publications analyzed,
381 only 6 were related to chronic stages of the cartilage
382 defect.34,63,64,75,111,113 It is recognized that a chronic cartilage
383 lesion is a diverse condition as compared to an acute cartilage
384 lesion.26,34,145 This fact highlights the importance of addressing
385 the correct stage of lesion progression in animal models when
386 translating to human treatment.
387 As for tissue characterization, the majority of the studies
388 included immunohistochemical evaluation of the neo-cartilage
389 by evaluating the presence of collagen type I and type II,
390 whereas expression of type X was determined in only 3
391 studies.19,115,132 It is important to identify the expression of
392 collagen type X, in order to exclude the possibility of
393 hypertrophic tissue development or a transient cartilage.64
394 Determination of gene expression was performed in 24
395 studies. In these, an increase in cartilage-related gene expression
396 was found in the regenerated tissue. Nevertheless, given the
397 mismatch of information regarding gene expression, it is not
398 possible to perform a full comparison between studies.
399 Assessment of mechanical performance of the new tissue is a
400 relevant dimension when evaluating quality of the cartilage
401repair. Yet, its implementation is diﬃcult, as it depends on
402anatomical location, measurement methodology and speciﬁc
403conditions of the joint.66 The mechanical properties of the
404repaired tissue were evaluated in only 8 studies. In most of
405these, properties of the new tissue were similar or close to
406native cartilage.24,32,34,77,114 Some authors found inconsistent
407results75 and repaired tissue showed a higher stiﬀness as
408compared to normal cartilage.24,94 As expected, similar
409mechanical properties between repaired tissue and normal
410cartilage was correlated with regenerated hyaline-like cartilage,
411except for the study by Pulkkinen et al.,32 which despite
412mechanical properties being similar to native cartilage, the
413repaired tissue did not correspond histologically to hyaline-like
414cartilage. From these studies, two main issues can be
415highlighted: (i) large variety of reported methodologies
416among studies for determining mechanical performance of
417regenerated cartilage; (ii) adopted methodologies that do not
418reﬂect natural physiological condition.66 These issues pose
419additional challenges when assessing quality of the regenerated
420cartilage in animal models using new biomaterial/therapeutic
421candidates, and when translating such performance during
422proof-of-concept or preclinical setting, to human performance
423in clinical setting.
424The majority of the studies did not compare the treatment
425groups with reference treatments, adopted as clinical standard,
426such as microfracture or osteochondral grafting, which would
427be of high value to infer the relative eﬃcacy of the new
428biomaterial/therapeutic candidates. For full-thickness defects
429(the most frequent defect type studied), the nontreated control
430group acts in a similar way to microfracture as there is exposure
431to bone marrow. Yet, for partial-thickness defect, only 1 study
432compared the outcome with microfracture treatment.86
433Concerning osteochondral grafting, only 2 studies compared
434the results of between scaﬀold treated groups with osteochon-
435dral grafting.34,48
436Regarding the use of cells, most studies used chondrocytes,
437although mesenchymal stem cells (MSC) have been also highly
438explored.39 Adipose mesenchymal stem cells (aMSC), muscle
439mesenchymal stem cells (mMSC), synovium mesenchymal
440stem cells (sMSC), and bone-marrow mesenchymal stem cells
441(bmMSC) were used, which avoid donor site morbidity in the
442cartilage tissue. Among the diﬀerent stem cell sources, it was
443stated that sMSC and bmMSC show a greater chondrogenic
444potential as compared to aMSC or mMSC, while one study
445reported, in addition, greater proliferation potential of sMSC.28
446Many researchers have reported an improvement in bone and
447cartilage formation39,59 when MSC were implanted. These
448improvements were promising, with a superior cartilage
449bonding to adjacent native cartilage, when compared with
450articular chondrocytes.64 However, some authors44,50,54,121 did
451not ﬁnd better results in cartilage regeneration when MSCs
452were used.
453Regarding the the use of growth factors, a relationship
454between use of growth factors and inﬂammatory response or
455pathological changes, was not found. However, reported
456responses were identiﬁed in only 5 experiments that have
457used growth factors.24,31,62,63,65 For 1 case using BMP-2,
458extensive ectopic bone formation was observed.31
459TGF−β seems to be dose-dependent and lower concen-
460trations are more eﬀective in repairing cartilage defects and
461decrease osteophyte formation.62 TGF-β1 has been suggested
462to have a pro-inﬂammatory response, but no study using TGF-
463β1 reported an inﬂammatory response. TGF−β1 promoted
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464 trabecular bone subchondral appearance but did not improve
465 cartilage cell morphology or glycosaminoglycan (GAG)
466 expression,44 while TGF-β3 was suggested to have a chemo-
467 tactic cue for cell homing.114 The combination of BMP-7 and
468 TGF-β1 was found to induce chondrogenic diﬀerentiation.115
469 To be considered mature hyaline cartilage, the repaired tissue
470 must exhibit normal morphology of chondrocytes and normal
471 safranin O staining and possess an adequate structural
472 organization with vertical columnar alignment of chondrocytes.
473 When the last condition is not attained, the repair tissue is
474 classiﬁed as immature. If the tissue is composed of dense
475 spindle-shaped ﬁbroblasts, the tissue is graded as ﬁbrous tissue.
476 When the repair tissue contains cells beginning to diﬀerentiate
477 toward chondrocytes, the tissue is called as undiﬀerentiated
478 mesenchymal tissue.48,146 Another important aspect is that 3
479 studies did not obtain statistically signiﬁcant improvement in
480 treated groups when compared with untreated group.30−32
481 Although the majority of studies reported improvement of
482 cartilage regeneration in treated groups, 22 studies did not
483 recognize formation of hyaline-like cartilage at the repaired
484 defect site. Therefore, better scoring of repaired tissue does not
485 mean necessarily hyaline-like cartilage formation. Further
486 discussion might focus on reliability and adequacy of scores
487 used to evaluate regenerated cartilage tissue. Bonasia et al,
488 tested the inter- and intraobserver reliability of 10 scores and
489 concluded that, for evaluation of cartilage repair in animal
490 models, the ICRS II, O’Driscoll and modiﬁed O’Driscoll scores
491 are preferential given their high reliability, and the fact that the
492 whole joint is available for histological assessment.147 On the
493 other hand, for evaluation of human cartilage biopsies, the
494 ICRS I or II or Oswestry score are preferable given the limited
495 tissue available.147
496 The studies analyzed herein evaluated repaired tissue mostly
497 by the O’Driscoll score, followed by the Wakitani. One of the
498 limitations of these scores relate to the lack of validation by
499 biochemical analysis.148 Only the Bern score has undergone
500 such validation, yet has been considered more adequate for
501 analysis of tissue-engineered constructs148 instead of repair of
502 cartilage in animal models. Accordingly, it was not used in any
503 of the revised studies. For the O’ Driscoll score, safranin O
504 staining grading is not reﬂected in the ﬁnal score and a limited
505 diﬀerence was observed between a “moderate” and a “poor”
506 quality of regenerated cartilage.148 Although the O’ Driscoll
507 score includes evaluation of repaired tissue structure, it does
508 not consider other parameters such as mineral degeneration,
509 vascularity, subchondral bone, viability cell population,
510 inﬂammation, and cartilage plug quality.148 As previously
511 reported,149 evaluation of cartilage repair should make use of
512 more than one score, complemented by biochemical,
513 automated histomorphometry, and biomechanical correlation.
514 Data Correlation. Given the above-mentioned compilation
515 of data, one would be tempted to understand which
516 combination of factors would seem the most promising in
517 yielding regeneration of cartilage tissue. Despite the high
518 number of variables and possible combinations, an excel VBA
519 application was developed in order to correlate data. Studies
520 were characterized as “hyaline” or “no hyaline” based on the
521 studies’ author classiﬁcation of repaired tissue. Subsequently,
522 studies were selected based on the use or no use of cells (C)
523 and/or growth factors (GF), by animal model or lesion size,
524 ultimately correlated by type of scaﬀold (natural, synthetic, or
525 combined materials). Outcomes are displayed in Figure 3.
526Regarding the animal model (Figure 3A), despite the rabbit
527not being recommended as a model to evaluate cartilage repair
528due to small cartilage thickness, and high spontaneous
529regeneration,150,151 when analyzing Figure 3A, it is evident
530that among all animal models, the rabbit has been the most
531widely used, comprising 73.3% of all studies. Of these, 62.9%
532claimed to have generated hyaline-like cartilage tissue.
533Apparently, combined scaﬀolds were responsible for such
534outcome, comprising 41.2% of the hyaline repaired tissue.
535Nevertheless, for bigger animal models (goat, sheep, and mini
536pig), the natural origin scaﬀolds seem to result in superior
537hyaline-like cartilage regeneration, as compared to those using
538combined or synthetic hydrogels.
539When analyzing from another perspective, it was possible to
540determine that 55.6% of all rabbit studies used combined
541scaﬀolds, and these generated 65.6% of all hyaline-positive
542outcomes. This trend is maintained for all animal models,
543whereas the synthetic scaﬀolds seem to yield inferior outcomes.
544Figure 3B1 displays an analysis of the combination of cells
545(C) and/or growth factors (GF) with the diﬀerent types of
546hydrogels, and their synergistic eﬀect on cartilage repair. In fact,
547of all studies analyzed, 51.5% used hydrogels composed of
548combined materials and resulted in a 70.6% success rate on
549generating hyaline-like cartilage. Those using scaﬀolds of
550natural origin (38.6%) seem less successful, where only 45.1%
551generated hyaline regeneration. Nevertheless, it does seem that
552the presence of cells generally improve probability of successful
553regeneration of tissue, as major percentage of successful
554outcomes where achieved through the use of cells in
555combination with the scaﬀold, while the positive eﬀect of the
556presence of growth factors is not so evident (Figure 3B1).
557An additional correlation factor was lesion size, where type of
558scaﬀold (natural, synthetic or combined), was related to the
559lesion area (<3 mm2, 3−6 mm2, or >6 mm2) and relative
560percentage of incidence on generating hyaline cartilage was
561analyzed (Figure 3B2). Overall, hydrogels of combined
562materials seem to perform better than natural or synthetic
563hydrogels, in nearly all dimension ranges, yet it seems that for
564larger lesions, natural origin hydrogels provided better
565outcomes.
566On what regards deepness of lesion (Figure 3B3), full-
567thickness was the most used and the most successful in
568obtaining hyaline cartilage, according to their authors.
569However, interpretation of this outcome is limited to the
570reduced number of studies that have tested repair of partial
571lesions (only 5% of all studies).
572Study Limitations Acknowledged by Authors. Some
573authors pointed several limitations in their studies: the
574dimension of the sample27,30,34,39,67,103,43,108 and speciﬁc
575problems with design of the study.44,65,96,101,102 In addition,
576several limitations have been pointed out, such as lack of
577biomechanical evaluation,28,67,99,104−106,112,129,131 short follow-
578up,27,43,62,77,101,103,105,106,109,113,122,130,131 animal immaturity,
579and type of animal model,77,104,105,110,117 poor representative-
580ness of human pathology,93 origin-cell identiﬁcation not
581possible in the majority of the studies,25,26,67,131 absence of a
582speciﬁc rehabilitation program,113 and experimentation under
583no load bearing conditions.34,106 The International Cartilage
584Repair Society (ICRS)150 and the American Society for Testing
585and Materials (ASTM)151 have published guidelines and
586recommendations for preclinical studies aiming cartilage repair,
587that could be considered by researchers in order to generate
588valuable and comparable data, ultimately contributing to
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589 stronger advancement of knowledge in the ﬁeld of cartilage
590 repair.
5. CONCLUSIONS
591 In summary, hydrogel biomaterials seem to be promising
592 candidates for cartilage repair, given that hyaline-like cartilage
593 development was proved in a considerable number of studies. A
594 potential advantage of using hydrogels for cartilage repair is its
595 suitability for arthroscopic delivery, yet, in many studies,
596 hydrogel properties did not seem compatible with this
597 minimally invasive approach. Overall, further development on
598 surgical technique will be required.
599 The majority of the published papers addressed small, acute
600 and a full-thickness cartilage defect in a nonweight bearing area.
601 These conditions are very diﬀerent from those found in human
602 patients which is a concerning limitation considering translation
603 of experimental learnings toward human treatment. The need
604 for animal models and experimental designs that consider those
605 aspects is obvious and must be considered in future animal
606 experimentation studies.
607 In addition, anticipation of potential therapeutic eﬃcacy in
608 human demands a more conclusive mechanical evaluation of
609 the regenerated tissue, as well as long-term studies. Not less
610 important is the need of standardization of the evaluation
611 procedures, especially on what concerns histology in order to
612 enable comparison among diﬀerent studies. The use of uniform
613 guidelines for the deﬁnition of the general conditions and
614 techniques to be used in cartilage repair experiments is
615 mandatory to ensure comparability of studies.
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